E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/13/2011 in the Prospect News Emerging Markets Daily.

New Issue: China's Sinopharm prices RMB 2 billion 4.89% three-year bonds at par

By Jennifer Chiou

New York, May 13 - Sinopharm Group Co. Ltd. announced the issue of a RMB 2 billion first tranche of bonds at par to yield 4.89%.

The three-year bonds were priced at RMB 100 per unit, with a minimum subscription amount of RMB 5 million.

The issue received approval from the board of directors in November 2010. At the time, the company said it planned to price up to RMB 5 billion of medium-term bonds in one or more tranches.

The Beijing-based pharmaceutical company plans to use the proceeds to fund its operational activities, to increase liquidity and to repay bank loans.

Issuer:Sinopharm Group Co. Ltd.
Issue:Medium-term bonds
Amount:RMB 2 billion
Maturity:2014
Coupon:4.89%
Price:Par of RMB 100
Yield:4.89%
Settlement date:May 13

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.